Bioceres Subsidiary Raises $25.9M in Bond Offering

TL;DR

Bioceres subsidiary Rizobacter just closed a $25.9M bond sale. Bullish.

AI Summary

Bioceres Crop Solutions Corp. announced that its subsidiary, Rizobacter Argentina S.A., successfully completed an offering of Series X Corporate Bonds, raising $25.9 million. This offering took place on November 25, 2024, and is part of the company's ongoing financial activities.

Why It Matters

This bond offering provides Rizobacter Argentina S.A. with capital, potentially for expansion or operational needs, which could impact its market position and Bioceres Crop Solutions' overall financial health.

Risk Assessment

Risk Level: low — The filing is a routine 6-K report detailing a completed bond offering by a subsidiary, with no immediate negative indicators.

Key Numbers

• $25.9M — Bond Offering Proceeds (Amount raised by subsidiary Rizobacter Argentina S.A.)

Key Players & Entities

• Bioceres Crop Solutions Corp. (company) — Registrant
• Rizobacter Argentina S.A. (company) — Subsidiary completing bond offering
• $25.9 Million (dollar_amount) — Amount raised from bond offering
• November 25, 2024 (date) — Date of bond offering completion

FAQ

Key Financial Figures

• $25.9 Million — ary Rizobacter Argentina S.A. Completes $25.9 Million Offering of Series X Corporate Bonds
• $25.9 million — uo;Rizobacter”) has completed a US$25.9 million public offering of Series X corporate b
• $2.4 million — wo tranches: Class A : Approximately US$2.4 million 7.0% p.a. bonds due November 2026; and
• $23.5 million — er 2026; and Class B : Approximately US$23.5 million 8.0% p.a. bonds due November 2027. Pro

Filing Documents

• tm2429847d1_6k.htm (6-K) — 15KB
• tm2429847d1_6kimg001.jpg (GRAPHIC) — 4KB
• 0001104659-24-124558.txt ( ) — 22KB

Forward-looking statements

Forward-looking statements This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the Company’s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management’s expectations or could affect the Company’s ability to achieve its strategic goals, including the uncertainties relating to the impact of the armed conflict between Israel and Gaza, the Ukraine and Russia, and of COVID-19 on the Company’s business, operations, liquidity and financial results and the other factors that are described in the sections entitled “Risk Factors” in the Company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOCERES CROP SOLUTIONS CORP. (Registrant) Dated: December 2, 2024 By: /s/ Federico Trucco Name: Federico Trucco Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR